Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39419061

Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2024 Nov
First author
Provencio M

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2024 Nov;25(11):e542. doi: 10.1016/S1470-2045(24)00593-X.
    note
    Source null
    related pmid
    39481412
    relationship
    Erratum in
  2. citation
    Transl Lung Cancer Res. 2025 May 30;14(5):1882-1886. doi: 10.21037/tlcr-2025-202.
    note
    Source null
    related pmid
    40535080
    relationship
    Comment in
  3. citation
    Transl Lung Cancer Res. 2025 Jul 31;14(7):2383-2386. doi: 10.21037/tlcr-2025-364.
    note
    Source null
    related pmid
    40799436
    relationship
    Comment in
  4. citation
    Transl Lung Cancer Res. 2025 Nov 30;14(11):4704-4710. doi: 10.21037/tlcr-2025-883.
    note
    Source null
    related pmid
    41367577
    relationship
    Comment in

Authors and identifiers

  1. name
    Provencio M
    type
    Author
  2. name
    Nadal E
    type
    Author
  3. name
    Insa A
    type
    Author
  4. name
    García Campelo R
    type
    Author
  5. name
    Casal J
    type
    Author
  6. name
    Dómine M
    type
    Author
  7. name
    Massuti B
    type
    Author
  8. name
    Majem M
    type
    Author
  9. name
    Rodríguez-Abreu D
    type
    Author
  10. name
    Martínez-Martí A
    type
    Author
  11. name
    de Castro J
    type
    Author
  12. name
    Gómez de Antonio D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Provencio M
    type
    Author
  2. name
    Nadal E
    type
    Author
  3. name
    Insa A
    type
    Author
  4. name
    García Campelo R
    type
    Author
  5. name
    Casal J
    type
    Author
  6. name
    Dómine M
    type
    Author
  7. name
    Massuti B
    type
    Author
  8. name
    Majem M
    type
    Author
  9. name
    Rodríguez-Abreu D
    type
    Author
  10. name
    Martínez-Martí A
    type
    Author
  11. name
    de Castro J
    type
    Author
  12. name
    Gómez de Antonio D
    type
    Author
bibliography ids
  1. nci-bib-e4ab36af75957858652f1832
book metadata
content sha256
4e4abd36eb84382116c91f640a0903bc72185745f0005aa062e67f1e11dc0a8f
document type
citation
dois
  1. 10.1016/S1470-2045(24)00498-4
electronic publication date
display
2024 Oct 14
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:39419061
immutable id
pubmed:39419061@4e4abd36eb84382116c91f640a0903bc72185745f0005aa062e67f1e11dc0a8f
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1453-1464
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2024 Nov;25(11):e542. doi: 10.1016/S1470-2045(24)00593-X.
    note
    Source null
    related pmid
    39481412
    relationship
    Erratum in
  2. citation
    Transl Lung Cancer Res. 2025 May 30;14(5):1882-1886. doi: 10.21037/tlcr-2025-202.
    note
    Source null
    related pmid
    40535080
    relationship
    Comment in
  3. citation
    Transl Lung Cancer Res. 2025 Jul 31;14(7):2383-2386. doi: 10.21037/tlcr-2025-364.
    note
    Source null
    related pmid
    40799436
    relationship
    Comment in
  4. citation
    Transl Lung Cancer Res. 2025 Nov 30;14(11):4704-4710. doi: 10.21037/tlcr-2025-883.
    note
    Source null
    related pmid
    41367577
    relationship
    Comment in
outcomes validated
false
pmid
39419061
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
ce0639a768858a47556cec3376629db5dfeae63f7c9e9f14aaa05fe5c452beff
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2024 Nov
precision
month
year
2024
publication types
  1. Journal Article
  2. Clinical Trial, Phase II
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39419061/
title
Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial.

Preserved source evidence · Not medical advice